Persistence of CAR T Cells Seen in Next Generation Anti-BCMA Therapy, bluebird bio’s Ide-Cel

An executive from bluebird bio discusses recent results from the next-generation CAR T-cell therapy involving “memory” cells

Read the full article here

Related Articles